GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates A/S (OCSE:VIRO) » Definitions » Cash Receipts from Fees and Commissions

ViroGates A/S (OCSE:VIRO) Cash Receipts from Fees and Commissions


View and export this data going back to 2018. Start your Free Trial

What is ViroGates A/S Cash Receipts from Fees and Commissions?

Cash Receipts from Fees and Commissions only applicable to companies reporting Cash Flow from Operations in direct method.

ViroGates A/S (OCSE:VIRO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates A/S (OCSE:VIRO) » Definitions » Cash Receipts from Fees and Commissions
Comparable Companies
OCSE:SMSMED ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA ALGN XSWX:SOON SHSE:688271 ASX:COH LSE:SN. PODD OCSE:DEMANT BRKR BIO
Traded in Other Exchanges
N/A
Address
Banevaenget 13, Birkerod, DNK, DK-3460
Website
https://www.virogates.com
ViroGates A/S is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.